Great Lakes Gelatin Company was cited for marketing collagen hydrolysate and related products as drugs without FDA approval by making disease claims on their website and social media platforms, including claims that products could reduce joint pain and treat other conditions. The company violated the Federal Food, Drug, and Cosmetic Act by introducing these unapproved new drugs into interstate commerce and misbranding products intended for use in the cure, mitigation, treatment, or prevention of disease without proper drug classification and approval. The FDA's review of the company's website, Facebook, Pinterest, and YouTube channel between March and May 2021 identified multiple claims establishing the products' drug intent under section 201(g)(1)(B) of the Act.